Form EFFECT BYND CANNASOFT ENTERPRIS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 3, 2024 |
| Accession Number: | 0001493152-24-025823 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- INVEST Network (INVST) Presale Crosses $7.13M in Stage 3 as Solana Climbs Back Above $110, XRP Holds $1.50
- GivTrade Highlights Competitive Trading Costs and Low Spreads as Trading Costs Take Center Stage for Regional Traders
- European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disea
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
